Diplomat Pharmacy Inc
(DPLO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 5,492,524 | 4,485,230 | 4,410,388 | 3,366,631 | 2,214,956 |
| Cost of Goods | 5,116,515 | 4,211,085 | 4,144,802 | 3,103,392 | 2,074,817 |
| Gross Profit | 376,009 | 274,145 | 265,586 | 263,239 | 140,139 |
| Operating Expenses | 643,809 | 255,665 | 219,311 | 217,694 | 128,373 |
| Operating Income | -267,285 | 18,565 | 47,077 | 45,937 | 12,583 |
| Interest Expense | 41,650 | 10,716 | 6,573 | 5,239 | 2,528 |
| Other Income | 1,627 | 213 | -4,289 | 308 | -849 |
| Pre-tax Income | -307,308 | 8,062 | 36,215 | 41,006 | 9,206 |
| Income Tax | -5,039 | -7,126 | 11,195 | 16,234 | 4,655 |
| Net Income Continuous | -302,269 | 15,188 | 25,020 | 24,772 | 4,551 |
| Minority Interests | N/A | -322 | -3,253 | -1,004 | -225 |
| Net Income | $-302,269 | $15,510 | $28,273 | $25,776 | $4,776 |
| EPS Basic Total Ops | -4.07 | 0.23 | 0.43 | 0.42 | 0.12 |
| EPS Basic Continuous Ops | -4.07 | 0.22 | 0.38 | 0.41 | 0.13 |
| EPS Diluted Total Ops | -4.07 | 0.23 | 0.42 | 0.41 | 0.11 |
| EPS Diluted Continuous Ops | -4.07 | 0.22 | 0.37 | 0.39 | 0.12 |
| EPS Diluted Before Non-Recurring Items | 0.20 | 0.84 | 0.75 | 0.75 | 0.49 |
| EBITDA(a) | $59,526 | $87,786 | $98,298 | $77,741 | $21,088 |